Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
2.745
+0.045 (1.67%)
At close: Aug 6, 2025, 4:00 PM
2.740
-0.005 (-0.18%)
After-hours: Aug 6, 2025, 4:04 PM EDT
Despegar.com Market Cap
Savara has a market cap or net worth of $577.29 million as of August 6, 2025. Its market cap has decreased by -9.57% in one year.
Market Cap
577.29M
Enterprise Value
433.68M
1-Year Change
-9.57%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $577.29M, an increase of 335.03%. That is a compound annual growth rate of 19.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 473.60M | -10.12% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
| Apr 28, 2017 | 132.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.62B |
| Johnson & Johnson | 411.20B |
| AbbVie | 350.75B |
| AstraZeneca | 231.42B |
| Novartis AG | 228.98B |
| UnitedHealth Group | 227.69B |
| Abbott Laboratories | 227.46B |
| Novo Nordisk | 210.71B |